Tag Archives: Magnolia Medical Technologies

July 2022—Magnolia Medical Technologies, developers of the FDA 510(k)-cleared Steripath platform for reducing blood culture contamination for sepsis testing accuracy, announced the publication of results from a study performed by United Hospital Center, a member of the West Virginia University Health System.

Sept. 14, 2020―Magnolia Medical Technologies launched Mission to Zero, to bring greater awareness to the patient safety and antibiotic-associated risks caused by false-positive diagnostic test results for sepsis.